Genomics in Endpoints News: Supporting drug discovery and development

This article covers the launch of Genomics’ genetic analytics platform for drug discovery, Mystra, at the British Consulate in Boston, which had senior leaders from across the life sciences sector in attendance.

‍

By leveraging its extensive genomic database and proprietary algorithms, the article covers how Genomics partners with organisations to uncover novel drug targets and improve the success rates of clinical trials.

‍

The piece features quotes from Mishal Patel, head of AI at Novo Nordisk.

Originally featured in Endpoints News.